menu
    • menu
    [{"orgOrder":0,"company":"KGK Science","sponsor":"Joint Health Wellness Group, LLC.","pharmaFlowCategory":"DU","therapeuticArea":"Musculoskeletal","country":"CANADA","productType":"Carbohydrate","year":"2015","type":"Inapplicable","leadProduct":"Glucosamine Sulfate Potassium Chloride","moa":"Undisclosed","graph1":"Musculoskeletal","graph2":"Phase II","graph3":"KGK Science","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Musculoskeletal","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"KGK Science \/ Joint Health Wellness Group, LLC.","highestDevelopmentStatusID":"8","companyTruncated":"KGK Science \/ Joint Health Wellness Group, LLC."}]

    Find Clinical Drug Pipeline Developments & Deals for Glucosamine Sulfate Potassium Chloride

    Menu

    Glucosamine Sulfate Potassium Chloride

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            KGK Science

                            Canada arrow
                            ISPE Annual Meeting
                            Not Confirmed

                            KGK Science

                            Canada arrow
                            ISPE Annual Meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Glucosamine Sulfate Potassium Chloride

                            Therapeutic Area : Musculoskeletal

                            Study Phase : Phase II

                            Sponsor : Joint Health Wellness Group, LLC.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            A Study on the Efficacy of Glucosamine Sulfate Potassium Chloride/Standardized Ginkgo Biloba Leaf Extract in A...

                            Details : Glucosamine Sulfate Potassium Chloride is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Osteoarthritis, Knee.

                            Product Name : Undisclosed

                            Product Type : Carbohydrate

                            Upfront Cash : Inapplicable

                            November 13, 2015

                            Lead Product(s) : Glucosamine Sulfate Potassium Chloride

                            Therapeutic Area : Musculoskeletal

                            Highest Development Status : Phase II

                            Sponsor : Joint Health Wellness Group, LLC.

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth